Literature DB >> 33171286

A rare case of Clostridium paraputrificum bacteremia in a 78-year-old Caucasian man diagnosed with an intestinal neoplasm.

J Intra1, A Milano2, C Sarto2, P Brambilla2.   

Abstract

Clostridium like species, particularly Clostridium perfrigens, are the second most common causes of human anaerobic infections, including myonecrosis and bacteremia. Clostridium paraputrificum is an infrequent isolate, which has been identified in only 1% of reported cases of clostridial infections. We herein report a rare case of C. paraputrificum bacteremia in a 78-year-old Caucasian man diagnosed with an intestinal carcinoma and liver neoplastic lesions. The isolate was susceptible to chloramphenicol, meropenem, metronidazole, vancomycin, and resistant to clindamycin and penicillin, and the patient was successfully treated with metronidazole. Malignancy and inflammatory bowel diseases are often associated with clostridial bacteremia, which cannot be neglected.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bacteremia; Clostridium paraputrificum; Intestinal neoplasm; MALDI-TOF; Underlying medical conditions

Year:  2020        PMID: 33171286     DOI: 10.1016/j.anaerobe.2020.102292

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  2 in total

1.  Clostridium paraputrificum bacteremia in a patient with presumptive complicated appendicitis: A case report.

Authors:  Zachary Mostel; Allyson Hernandez; Luis Tatem
Journal:  IDCases       Date:  2021-12-06

2.  Investigating the infant gut microbiota in developing countries: worldwide metagenomic meta-analysis involving infants living in sub-urban areas of Côte d'Ivoire.

Authors:  Rossella D'Alfonso; Christian Milani; Federico Fontana; Leonardo Mancabelli; Gabriele Andrea Lugli; Chiara Taracchini; Giulia Alessandri; Giulia Longhi; Rosaria Anzalone; Alice Viappiani; Roch Famo; Marc Brognan; Kouamé Hervé Micondo; Francesca Turroni; Marco Ventura
Journal:  Environ Microbiol Rep       Date:  2021-06-21       Impact factor: 3.541

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.